Status:

RECRUITING

A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM

Lead Sponsor:

Lexeo Therapeutics

Conditions:

Arrhythmogenic Cardiomyopathy

PKP2-ACM

Eligibility:

All Genders

18-65 years

Brief Summary

An observational study to assess real-world patient characteristics and clinical course of disease in participants with PKP2-ACM.

Detailed Description

SNAPSHOT-PKP2 is an observational, multicenter study that consists of 2 parts, a retrospective EMR review (up to 2 years) and a prospective observational study (1 year), to evaluate the clinical burde...

Eligibility Criteria

Inclusion

  • Adults with a clinical diagnosis of ACM as defined by the 2010 revised Task Force Criteria (TFC)
  • Documentation of a pathogenic or likely pathogenic truncating variant in PKP2
  • Frequent premature ventricular contractions (PVCs)
  • Patients must have an ICD placed prior to enrollment
  • Left ventricular ejection fraction (LVEF) ≥ 50% for Part A participants. Left ventricular ejection fraction (LVEF) ≥40% for Part B participants.

Exclusion

  • Evidence of variant(s) in addition to PKP2 that meet standard criteria to be considered pathogenic or likely pathogenic for an arrhythmogenic cardiomyopathy.
  • A history of other cardiac abnormalities as specified in the protocol.
  • New York Heart Association symptoms of heart failure of Class IV at the time of consent.
  • A history of prior gene transfer therapy.

Key Trial Info

Start Date :

January 23 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2027

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06976606

Start Date

January 23 2024

End Date

September 1 2027

Last Update

May 16 2025

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Leland Stanford Junior University

Redwood City, California, United States, 94063-3126

2

Johns Hopkins University

Baltimore, Maryland, United States, 21287

3

Northshore University Healthsystem Research Institute

Columbia, Maryland, United States, 21044

4

University of Michigan

Ann Arbor, Michigan, United States, 48109

A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM | DecenTrialz